Structurally Rigid Dopamine D3 Receptor Selective Ligands as Cocaine and Methamphetamine Abuse Therapeutics
US Application 60/410,715
Filed on 2002-09-14
Filed on 2002-09-14
Identification And Targeting of Consensus Sites By Which Dynorphin Exerts Its Neurotoxicity Effects Enables Analgesia Without...
US Application 60/459,830
Filed on 2003-04-01
Filed on 2003-04-01
Coil For Magnetic Stimulation and Methods For Using The Same
US Application 60/242,297
Filed on 2000-10-20
Filed on 2000-10-20
TREATMENT OF SCHIZOPHRENIA, BIPOLAR DISORDER, AND CLUSTER SYNDROMES AS A NEURAL PLASTICITY DISORDER BY MODULATION OF N-CAM FRAGMENTS IN
US Application 60/177,971
Filed on 2000-01-25
Filed on 2000-01-25
cDNA Fragment T155c, From SV 40 Gene SV40 Large T, for Immortalizing Cells
US Application 60/136,492
Filed on 1999-05-28
Filed on 1999-05-28
SUBTAINED RELEASE DERIVATIVES OF HYDROXYLATED ANALOGS OF SUBSTITUTED 1-[2[BIS(ARYL)METHOXY]ETHYL]-PIPERAZINES AND -HOMOPIPERAZINES AND ...
US Application 60/030,248
Filed on 1996-10-31
Filed on 1996-10-31
4' AND 4',4 -SUBSTITUTED-3a-(DIPHENYLMETHOXY)TROPANE ANALOGS AS COCAINE THERAPEUTICS
US Application 60/000,378
Filed on 1995-06-21
Filed on 1995-06-21
Method and Apparatus for the Capture of Intra-cellular Activity
US Application 18/135,738
Filed on 2023-04-18
Filed on 2023-04-18
DUAL-TARGETED OPIOID AND DOPAMINE D3 RECEPTORS LIGANDS PREPARATION AND USE THEREOF
Patent Cooperation Treaty
PCT/US2024/018704
Filed on 2024-03-06
PCT/US2024/018704
Filed on 2024-03-06
FLUORINATED MU-OPIOID RECEPTOR AGONISTS
Patent Cooperation Treaty
PCT/US2023/082355
Filed on 2023-12-04
PCT/US2023/082355
Filed on 2023-12-04